ESR1 and breast carcinoma: In addition, the AMPA-associated hypomethylation at the ESR1 promoter is interesting, given the potential link between AMPA and breast cancer risk [28] and the potential for glyphosate/AMPA-induced endocrine disruption, reviewed in this paper.